| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 6.20 | 8.4% | 1.1% |
| Total Income | 6.20 | 8.4% | 1.1% |
| Expenditure | 9.34 | 24.0% | 0.4% |
| PBT | -3.16 | 51.8% | 3.3% |
| Net Profit | -3.17 | 51.7% | 2.9% |
| OPM | -50.69% | 1.11pp | |
| NPM | -51.17% | 0.84pp | |
| EPS | -0.20 | 65.5% | 42.9% |
Lifeward Ltd. Announces Financial Results for Q3 2025
04 May 2026 · 4 May, 7:10 am
Summary
Lifeward Ltd. announced its financial results for the third quarter ended September 30, 2025. The company entered into a secured promissory note with Oramed Ltd. for $3.0 million, with interest accruing at 15% per annum. A conference call was scheduled to discuss the financial results on November 14, 2025. The secured promissory note is convertible into ordinary shares at $0.45 per share.
Key Highlights
- 1
Lifeward Ltd. announced its financial results for the third quarter ended September 30, 2025.
- 2
The company will host a conference call on November 14, 2025, to discuss the financial results.
- 3
A secured promissory note with Oramed Ltd. was entered into for a principal amount of $3.0 million.
- 4
Interest on the loan accrues at a rate of 15% per annum, maturing on May 14, 2026.
Informational and educational content only. Not investment advice.